Susquehanna International Group’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-7,060
| Closed | -$76.5K | – | 6592 |
|
2022
Q4 | $76.5K | Buy |
7,060
+3,241
| +85% | +$35.1K | ﹤0.01% | 5051 |
|
2022
Q3 | $81K | Buy |
3,819
+735
| +24% | +$15.6K | ﹤0.01% | 5357 |
|
2022
Q2 | $123K | Sell |
3,084
-2,656
| -46% | -$106K | ﹤0.01% | 4895 |
|
2022
Q1 | $321K | Buy |
5,740
+1,848
| +47% | +$103K | ﹤0.01% | 4270 |
|
2021
Q4 | $162K | Sell |
3,892
-1,451
| -27% | -$60.4K | ﹤0.01% | 5086 |
|
2021
Q3 | $442K | Buy |
+5,343
| New | +$442K | ﹤0.01% | 3859 |
|
2021
Q2 | – | Sell |
-3,391
| Closed | -$373K | – | 5826 |
|
2021
Q1 | $373K | Sell |
3,391
-1,173
| -26% | -$129K | ﹤0.01% | 4141 |
|
2020
Q4 | $461K | Buy |
4,564
+4,128
| +947% | +$417K | ﹤0.01% | 3499 |
|
2020
Q3 | $49K | Buy |
+436
| New | +$49K | ﹤0.01% | 4219 |
|
2018
Q4 | – | Sell |
-343
| Closed | -$67K | – | 4657 |
|
2018
Q3 | $67K | Buy |
+343
| New | +$67K | ﹤0.01% | 3031 |
|